Projects per year
Fingerprint
Dive into the research topics where Saurabh Chhabra is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
BMT Core- Medical College of Wisconsin
Shah, N. N. (PI), Hari, P. (CoPI) & Chhabra, S. (CoPI)
National Heart, Lung, and Blood Institute
7/27/17 → 6/30/25
Project: Research project
-
Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma
Sidana, S., Patel, K. K., Peres, L. C., Bansal, R., Kocoglu, M. H., Shune, L., Atrash, S., Smith, K., Midha, S., Ferreri, C., Dhakal, B., Dima, D., Costello, P., Wagner, C., Reshef, R., Hosoya, H., Mikkilineni, L., Atanackovic, D., Chhabra, S. & Parrondo, R. & 18 others, , Jan 2 2025, In: Blood. 145, 1, p. 85-97 13 p.Research output: Contribution to journal › Article › peer-review
-
Surrogates of Endothelial Injury Predict Survival After Post-transplant Cyclophosphamide
Baranwal, A., Langer, K. J., Kharfan-Dabaja, M. A., Ayala, E., Foran, J., Murthy, H., Roy, V., Iqbal, M., Palmer, J., Sproat, L. Z., Chhabra, S., Khera, N., Durani, U., Hefazi, M., Mangaonkar, A., Shah, M. V., Litzow, M. R., Hogan, W. J. & Alkhateeb, H. B., Jan 2025, In: Transplantation and Cellular Therapy. 31, 1, p. 16.e1-16.e9Research output: Contribution to journal › Article › peer-review
-
An open-label, first-in-human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myeloma
Kapoor, P., Nathwani, N., Jelinek, T., Pour, L., Perrot, A., Dimopoulos, M. A., Huang, S. Y., Spicka, I., Chhabra, S., Lichtman, E., Mateos, M. V., Kanagavel, D., Zhao, L., Guillemin-Paveau, H., Macé, S., van de Velde, H. & Richardson, P. G., Nov 2024, In: European Journal of Haematology. 113, 5, p. 593-605 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.
Wolff, D., Cutler, C., Lee, S. J., Pusic, I., Bittencourt, H., White, J., Hamadani, M., Arai, S., Salhotra, A., Perez-Simon, J. A., Alousi, A., Choe, H., Kwon, M., Bermúdez, A., Kim, I., Socié, G., Chhabra, S., Radojcic, V., O'toole, T. & Tian, C. & 3 others, , Sep 19 2024, In: New England Journal of Medicine. 391, 11, p. 1002-1014 13 p.Research output: Contribution to journal › Article › peer-review
-
Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study
Mohan, M., Kothari, A., Verhagen, N., Shreenivas, A., Radhakrishnan, S. V., Dhakal, B., Figueroa-Castro, C., Chhabra, S., Janz, S., Pasquini, M., Hamadani, M., Szabo, A. & D’Souza, A., Jan 2024, In: Bone Marrow Transplantation. 59, 1, p. 121-124 4 p.Research output: Contribution to journal › Letter › peer-review